Significant milestone reached – product tested on patient
Today, the first patient was included in the clinical study underway at the children's hospital Sachsska barnsjukhuset, part of Södersjukhuset. For Calmark, this marks the reaching of one of the last remaining milestones for 2019, out of the ones previously disclosed.The study will include 40 children with suspected elevated levels of bilirubin (risk of jaundice), where blood tests have to be taken. The existing point-of-care (POC) analysis methods for bilirubin assessment employ transcutaneous measurement or blood gas analyzers, but these methods fail to address the needs of all